JACLYN THORESZ: Open Payments
NPI 1558399337 · GREAT NECK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,101 in 110 payments from 15 companies in 2025. Trend: 2023 $3,226 · 2024 $2,884 · 2025 $3,101
Food & beverage: $2,701Consulting: $400
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $979 |
| GlaxoSmithKline, LLC. | 23 | $537 |
| Verona Pharma, Inc. | 16 | $368 |
| Regeneron Healthcare Solutions, Inc. | 11 | $274 |
| Insmed, Inc. | 7 | $160 |
| Viatris Specialty LLC | 12 | $142 |
| Actelion Pharmaceuticals US, Inc. | 5 | $137 |
| GENZYME CORPORATION | 1 | $128 |
| Baxter Healthcare | 5 | $117 |
| United Therapeutics Corporation | 3 | $82 |
Products named: AIRSUPRA, DUPIXENT, Ohtuvayre, NUCALA, TRELEGY ELLIPTA, FASENRA, TEZSPIRE, Arikayce.
Industry payments across NY — which companies pay providers there.
